VITAMIN AD - retinol cholecalciferol injection 
Phoenix Pharmaceutical Inc

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

VITAMIN AD INJECTION

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

INDICATIONS

For use as a supplemental nutritive source of vitamins A and D in cattle, sheep and swine.

CAUTION

Do not inject into meat animals within 60 days of marketing. 

Administration of this product to well nourished animals may cause hypervitaminosis D which may result in hypercalcemia.  This condition may be harmful to the animal.

DOSAGE AND ADMINISTRATION

Inject intramuscularly or subcutaneously preferably  in the neck area using aseptic technique.

Calves - 1/2 to 1 mL

Adult Cattle - 2 to 4 mL

Lambs - 1/4 to 1/2 mL

Adult Sheep - 1 to 2 mL

Weaning Pigs - 1/4 to 1/2 mL

Adult Swine - 1 to 2 mL

These suggested dosage may be repeated after 60 days, if necessary.

TAKE TIME OBSERVE LABEL DIRECTIONS

COMPOSITION

Each mL of sterile solution contains:
Vitamin A  . . . . . . . . . 500,000 IU
Vitamin D3  . . . . . . . . . 75,000 IU
In an emulsifiable base with vitamin E (antioxidant), N-methylpyrrolidone, polyoxyethylated (30) castor oil, propylene glycol dicaprylate, polyoxyethylene (20) sorbitan monooleate and benzyl alcohol 2%.

STORAGE

Store at controlled room temperature between 15o and 30oC (59-86oF).

Protect from light and excessive heat.

PX Vit AD

VITAMIN AD 
retinol cholecalciferol injection
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:57319-424
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RETINOL (UNII: G2SH0XKK91) (RETINOL - UNII:G2SH0XKK91) RETINOL500000 [iU]  in 1 mL
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL75000 [iU]  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57319-424-06250 mL in 1 VIAL
2NDC:57319-424-06250 mL in 1 VIAL
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/15/2004
Labeler - Phoenix Pharmaceutical Inc (150711039)

Revised: 10/2018
Document Id: 80545bc2-f820-412e-95b7-a45a3682c352
Set id: eaff2256-39c6-4210-b783-5d5cd1a85c6a
Version: 1
Effective Time: 20181023
 
Phoenix Pharmaceutical Inc